Chemours Investors Have Until December 7, 2026 to Seek Lead Plaintiff Role in Securities Fraud Lawsuit
Nov 9, 2026
Chemours investors have until December 7, 2026, to join a securities fraud class action alleging overstated Opteon demand caused an 18.63% share price drop. Eligible shareholders purchasing between February and August 2026 may participate.
Show all 47 updates